News
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
Sound Blade Medical, Inc., a leader in handheld histotripsy therapy, today announced the appointment of Neil Barman, M.D. as Chief Executive Officer. Dr. Barman, a physician-executive with more than ...
Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective ...
After six years of intensive research and testing, the Rhisotope Project has officially reached operational status – where rhinos will effectively be protected through nuclear technology. The project ...
Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic ...
Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer, effective August 7, 2025, the company announced on Tuesday.
Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as ...
Illinois Gov. JB Pritzker and former U.S. Commerce Secretary Penny Pritzker are at the center of an effort to drive more ...
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
NeuroScientific Biopharmaceuticals is transferring its patented tech to one of Australia’s most experienced stem cell ...
3d
InvestorsHub on MSNNovo Nordisk appoints Mike Doustdar as new CEO; Chief Scientific Officer to retire
Novo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment, with Melbourne-based exec Nathan Smith ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results